TY - GEN
T1 - Collagen-chitosan scaffold - Lauric acid plasticizer for skin tissue engineering on burn cases
AU - Widiyanti, Prihartini
AU - Setyadi, Ewing Dian
AU - Rudyardjo, Djony Izak
N1 - Publisher Copyright:
© 2017 Author(s).
PY - 2017/2/21
Y1 - 2017/2/21
N2 - The prevalence of burns in the world is more than 800 cases per one million people each year and this is the second highest cause of death due to trauma after traffic accident. Many studies are turning to skin substitute methods of tissue engineering. The purpose of this study is to determine the composition of the collagen, chitosan, and lauric acid scaffold, as well as knowing the results of the characterization of the scaffold. The synthesis of chitosan collagen lauric acid scaffold as a skin tissue was engineered using freeze dried method. Results from making of collagen chitosan lauric acid scaffold was characterized physically, biologically and mechanically by SEM, cytotoxicity, biodegradation, and tensile strength. From the morphology test, the result obtained is that pore diameter size ranges from 94.11 to 140.1 μm for samples A,B,C,D, which are in the range of normal pore size 63-150 μm, while sample E has value below the standard which is about 37.87 to 47.36 μm. From cytotoxicity assay, the result obtained is the percentage value of living cells between 20.11 to 21.51%. This value is below 50% the standard value of living cells. Incompatibility is made possible because of human error mainly the replication of washing process over the standard. Degradation testing obtained values of 19.44% - 40% by weight which are degraded during the 7 days of observation. Tensile test results obtained a range of values of 0.192 - 3.53 MPa. Only sample A (3.53 MPa) and B (1.935 MPa) meet the standard values of skin tissue scaffold that is 1-24 MPa. Based on the results of the characteristics of this study, composite chitosan collagen scaffold with lauric acid plasticizer has a potential candidate for skin tissue engineering for skin burns cases.
AB - The prevalence of burns in the world is more than 800 cases per one million people each year and this is the second highest cause of death due to trauma after traffic accident. Many studies are turning to skin substitute methods of tissue engineering. The purpose of this study is to determine the composition of the collagen, chitosan, and lauric acid scaffold, as well as knowing the results of the characterization of the scaffold. The synthesis of chitosan collagen lauric acid scaffold as a skin tissue was engineered using freeze dried method. Results from making of collagen chitosan lauric acid scaffold was characterized physically, biologically and mechanically by SEM, cytotoxicity, biodegradation, and tensile strength. From the morphology test, the result obtained is that pore diameter size ranges from 94.11 to 140.1 μm for samples A,B,C,D, which are in the range of normal pore size 63-150 μm, while sample E has value below the standard which is about 37.87 to 47.36 μm. From cytotoxicity assay, the result obtained is the percentage value of living cells between 20.11 to 21.51%. This value is below 50% the standard value of living cells. Incompatibility is made possible because of human error mainly the replication of washing process over the standard. Degradation testing obtained values of 19.44% - 40% by weight which are degraded during the 7 days of observation. Tensile test results obtained a range of values of 0.192 - 3.53 MPa. Only sample A (3.53 MPa) and B (1.935 MPa) meet the standard values of skin tissue scaffold that is 1-24 MPa. Based on the results of the characteristics of this study, composite chitosan collagen scaffold with lauric acid plasticizer has a potential candidate for skin tissue engineering for skin burns cases.
KW - chitosan
KW - collagen
KW - lauric acid
KW - scaffold
KW - skin tissue engineering
UR - http://www.scopus.com/inward/record.url?scp=85015990648&partnerID=8YFLogxK
U2 - 10.1063/1.4976765
DO - 10.1063/1.4976765
M3 - Conference contribution
AN - SCOPUS:85015990648
T3 - AIP Conference Proceedings
BT - Biomedical Engineering's Recent Progress in Biomaterials, Drugs Development, and Medical Devices
A2 - Whulanza, Yudan
A2 - Supriadi, Sugeng
A2 - Sahlan, Muhamad
A2 - Basari, null
PB - American Institute of Physics Inc.
T2 - 1st International Symposium of Biomedical Engineering: Biomedical Engineering's Recent Progress in Biomaterials, Drugs Development, and Medical Devices, ISBE 2016
Y2 - 31 May 2016 through 1 June 2016
ER -